Добірка наукової літератури з теми "Diabète de type 1 – chirurgie"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Diabète de type 1 – chirurgie".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Diabète de type 1 – chirurgie":
Scheen, A. J., J. De Flines, A. De Roover, and N. Paquot. "De la chirurgie bariatrique à la chirurgie métabolique : vers un nouveau paradigme dans le traitement du diabète de type 2." Médecine des Maladies Métaboliques 5, no. 3 (June 2011): 279–86. http://dx.doi.org/10.1016/s1957-2557(11)70240-1.
Pichlerová, Dita. "The role of bariatric surgery in patients with type 1 diabetes mellitus." Gastroenterologie a hepatologie 75, no. 6 (December 31, 2021): 524–28. http://dx.doi.org/10.48095/ccgh2021524.
Franck, M., J. de Flines, N. Paquot, A. De Roover, and A. Scheen. "P2146 Chirurgie bariatrique chez le patient diabétique de type 1 : résultats d’une expérience limitée." Diabetes & Metabolism 39 (March 2013): A102. http://dx.doi.org/10.1016/s1262-3636(13)72056-1.
Eas, F., G. Prévost, B. Cauliez, A. Laquerrière, P. Fréger, and J. Marc Kuhn. "029 Comparaison de l’efficacité de la chirurgie bariatrique dans le diabète de type 2 en fonction de la technique d’intervention. Analyse rétrospective chez 74 patients diabétiques opérés." Diabetes & Metabolism 37, no. 1 (March 2011): A8. http://dx.doi.org/10.1016/s1262-3636(11)70517-1.
Amouyal, C., and F. Andreelli. "Chirurgie métabolique du diabète de type 2." Médecine des Maladies Métaboliques 9, no. 5 (July 2015): 473–81. http://dx.doi.org/10.1016/s1957-2557(15)30200-5.
Jaffiol, Claude, and Patrick Ritz. "Chirurgie métabolique et diabète de type 2." Bulletin de l'Académie Nationale de Médecine 196, no. 7 (October 2012): 1473–75. http://dx.doi.org/10.1016/s0001-4079(19)31729-7.
Mrugala, Viktoria, and Albert J. Augustin. "Das frühe Diabetische Makulaödem: Ein Indikator für schlechte postoperative Ergebnisse nach Katarakt Chirurgie bei Diabetikern. Die DICAT-II-Studie." Kompass Ophthalmologie 7, no. 4 (2021): 184–86. http://dx.doi.org/10.1159/000520147.
D, Y. M. "Chirurgie bariatrique : un traitement du diabète de type 2." Option/Bio 25, no. 518 (December 2014): 10. http://dx.doi.org/10.1016/s0992-5945(14)72015-x.
Jean-Marie, Manus. "Chirurgie bariatrique, un traitement du diabète de type 2." Revue Francophone des Laboratoires 2024, no. 563 (2024): 13. http://dx.doi.org/10.1016/s1773-035x(24)76112-7.
Santucci, Nicolas, Sébastien Gaujoux, Christine Binquet, Cynthia Reichling, Jean-Christophe Lifante, Bruno Carnaille, François Pattou, et al. "Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d’étude des Tumeurs Endocrines) Study." World Journal of Surgery 45, no. 6 (March 1, 2021): 1794–802. http://dx.doi.org/10.1007/s00268-021-06005-7.
Дисертації з теми "Diabète de type 1 – chirurgie":
Maanaoui, Mehdi. "La greffe d'îlots pancréatiques chez le patient diabétique transplanté rénal." Electronic Thesis or Diss., Université de Lille (2022-....), 2023. https://pepite-depot.univ-lille.fr/ToutIDP/EDBSL/2023/2023ULILS071.pdf.
Pancreatic islet transplantation is an innovative cellular therapy for the management of diabetes in patients with type 1 diabetes. Currently, there are few studies that address the prognostic impact of islet transplantation in patients with type 1 diabetes who have received a kidney transplant or the determinants of transplantation success in this population. Furthermore, the definition of diabetes is evolving, with the dichotomy between type 1 and type 2 diabetes fading in favor of diabetes classifications based on the patient's clinical and biological phenotype. Pancreatic islet transplantation could potentially be expanded to other profiles of patients with diabetes and a kidney transplant, especially if there's evidence of insulin secretion deficiency. Thus, the objective of this thesis is to determine the role of pancreatic islet transplantation in patients with diabetes and a kidney transplant.In the first section, we present the results of a nationwide cohort study assessing the effect of pancreatic islet transplantation following kidney transplantation compared to insulin alone in patients with type 1 diabetes. Islet-after-kidney recipients were matched to control patients using a time-dependent propensity score. After matching, pancreatic islet transplantation is associated with a reduction in the combined risk of death and return to dialysis, as well as the isolated risk of death. This study emphasizes the importance of considering islet transplantation as a full-fledged therapeutic alternative, especially in regions where it is not reimbursed or available.The second section explores the determinants of islet loss of functionality, in particular the repercussions of alloimmunity. The results of a single-center study suggest that preformed DSA and early de novo DSA have little impact on islet transplantation outcomes, but late de novo DSA is temporally associated with impaired metabolic results. No cases of cross-sensitization between pancreatic islets and the underlying kidney in recipients were described, neither in the study nor in the literature.The last section focuses on evaluating the insulin profile in patients with type 2 diabetes and a kidney transplant, through the calculation of HOMA-2 scores, to extract the impact of insulin secretion. Analysis of a single-center retrospective cohort shows an association between insulin resistance evaluated by HOMA-2 and the risk of allograft loss, while insulin secretion was only associated with metabolic balance. However, given the relationship between metabolic balance and the likelihood of death and graft loss in kidney transplant patients with diabetes, pancreatic islet transplantation could be part of the therapeutic arsenal in a personalized medicine approach for these patients.In conclusion, this thesis advocates for personalized diabetes medicine in kidney transplant patients, promoting the integration of pancreatic islet transplantation as a key component in the therapeutic strategy for these individuals
Chopard-Lallier, Sophie. "Suivi fonctionnel de la greffe d'îlots de Langerhans : interêt de l'imagerie IRM et de l'immuno-monitoring cellulaire." Thesis, Besançon, 2013. http://www.theses.fr/2013BESA3001.
Langerhans islet transplantation allows curingtype 1 diabetes by restoring an endogenous insulin secretion. Halfof patients will resume insulin withinyears. This loss of function may be explained by the lack of monitoring tools able to diagnose an ongoing graft failure. The aims of our work were toevaluate the efficiency of MRI to diagnose islet graft rejection, and to assess the feasibility of immune cellular monitoring in transplanted patients.MRI in the rat mortelMethods: Syngeneic, allogeneic and xenogeneic islets were transplanted intra-portally to diabetic rats after labeling with superparamagnetic ironoxide nanoparticles (ferucarbotran). Images were acquired on a clinical 3T MRI scanner.Results: The signal decreasing was different between the 3 types of transplantations. At day 4, the MRI signal in allogeneic group was significantlylower while glycaemia remained normal. With a cut-off value of 84% at day 4, sensitivity of 91% and specificity of 70% were obtained.Cellular immune monitoringMethods: Mixed lymphocyte cultures were performed with peripheral blood mononuclear cells from recipients and splenocytes from donors. Immunereactivity was assessed by the release of IFNy (ELISpot), cell prolifération (flow cytometry of Ki67), and cytokine quantification (Bioplex). Theresults were correlated to the islet graft function assessed by (5-score.Results: Patients with low islet function showed higher cellular reactivity against donor cells assessed by ELISpot IFNy ((p=0,007, r=-0,50) andproliferation index (p=0,006, r=-0,51). Patients with low graft function had higher levels of IFNy, IL-5 and 1L-17
Sterkers, Adrien. "Evaluation pré-clinique et clinique de l'autogreffe intramusculaire d'îlots de Langerhans." Phd thesis, Université du Droit et de la Santé - Lille II, 2013. http://tel.archives-ouvertes.fr/tel-00951952.
Plourde, Charles-Étienne. "Les mécanismes de résolutions du diabète de type 2 induits par la chirurgie bariatrique." Mémoire, Université de Sherbrooke, 2015. http://hdl.handle.net/11143/6038.
Duchatelet, Sabine. "Recherche de gènes de prédiposition au diabète de type 1." Paris 6, 2006. http://www.theses.fr/2006PA066254.
Type 1 diabetes (T1D) is an autoimmune multifactorial disease. We used 3 strategies to find T1D susceptibility genes : the study of IDDM4 locus previously mapped on chromosome 11q13 by linkage, the search for genes responsible for monogenic syndromes with diabetes, and candidate gene approach. The study of IDDM4 locus led to identify variants associated with T1D, and to precisely bound the critical region. Our genetic studies, supplemented by functional studies, will allow us to detect the susceptibility gene at IDDM4 locus. Besides, we identified PTHR1 and GLIS3 genes responsible respectively for Eiken and NDH syndromes. We tested PTHR1 as a candidate gene, and a functional polymorphism in FCRL3 gene, reported as associated with several other autoimmune diseases, in the susceptibility to T1D. We did not detect significant association. Identification of T1D susceptibility genes will provide a better understanding of pathological processes involved in the development of the disease
Magdelaine, Nicolas. "Diabète de type 1 du modèle ... à la boucle fermée." Thesis, Ecole centrale de Nantes, 2017. http://www.theses.fr/2017ECDN0034.
For people living with type 1 diabetes, today’s treatment consists of a number of daily insulin injections in order to have a limited glycemic excursion. Poorly controlled glycemia leads to long term complications. In patient’s everyday life, functional insulin therapy helps patients to adjust insulin doses. The artificial pancreas could significantly improve glycemia equilibrium by means of an automated insulin infusion using continuous glucose monitoring. The first contribution of this thesis is a new model of the metabolism for type 1 diabetic. The interpretation of this model allows to compute the tools for the functional insulin therapy. Thus it becomes possible to advise the patient on how much insulin to inject. The ongoing clinical study will evaluate the impact of the model. The second contribution is a control-law that guaranties both hypoglycemia avoidance and positivity of the injection for the first time. It is inspired from the clinical practice. The theoretical proof makes use of the theory of positively invariant sets. The Hypo-Free Hyper-Minimizer is designed to regulate glycemia in a hybrid closed-loop whereas the Dynamic Bolus Calculator is designed for the fully-automated artificial pancreas. This control-law gathers clinical practice, artificial pancreas hard constraints, and theoretical proof and is being protected through a patent
Senée, Valérie. "Recherche de gènes de prédisposition au diabète de type 1." Paris 7, 2002. http://www.theses.fr/2002PA077174.
Dubois-Laforgue, Danièle. "Déterminisme génétique de l'expression phénotypique du diabète de type 1." Paris 5, 2002. http://www.theses.fr/2002PA05N112.
The genetics of type 1 diabetes (DT1) remains elusive. About twenty susceptibility regions have been localized by genome scans, of wich a minority have been confirmed. Moreover, causal genes remain to be characterized. Association studies have been more contributive, since they demonstrated the implication of HLA genes and of the insulin VNTR and suggested that of CTLA4 and IL-12B. One of the difficulties in studying genetics of DT1 relies in the phenotypic heterogeneity of the disease. We studied the genetics of type 1 diabetes and of its phenotypic expression through the study of three genes, SDF-1, PARP and NOTC, which constitue putative candidates because of their function and their localization in regions. .
Diaz, Valencia Paula Andrea. "Épidémiologie du diabète de type 1 : incidence mondiale et ses déterminants." Thesis, Paris 6, 2015. http://www.theses.fr/2015PA066698/document.
Background: The increase of worldwide incidence of type 1 diabetes (T1D) was calculated to be on average 3.0% per year and it was predicted that it would be 40% higher in 2010 in children aged 0-14 years. The causes of this increase are still under study; this thesis updates our current knowledge on the global incidence of T1D, and taking advantage of the increasing availability of public databases examines the correlation between incidence and country characteristics. Methods: A comprehensive systematic literature search of published articles on the incidence of T1D worldwide was conducted to study global variations of the incidence within countries. The initial goal of this thesis was to study the correlation between environmental variables available in public databases with the country incidence of T1D. Conclusions and implications: During this thesis, we quantified the country-to-country variation in T1D incidence worldwide in children and adults, and show that a large part of this incidence could be accounted for by the variability of environmental factors within the countries taking advantage of the increasing availability of public databases. Environmental factors may be involved in the strong cohort effect we found; it is advisable to deepen the research on pregnancy and neonatal period and its implications on T1D. Here we could quantify that the increase of T1D was even larger than had been predicted in an earlier study
Sauter, Pierre. "Infection à coxsackievirus B4 dépendante d'anticorps et diabète de type 1." Lille 2, 2008. http://www.theses.fr/2007LIL2S038.
Книги з теми "Diabète de type 1 – chirurgie":
Galibois, Isabelle. Le diabète de type 1 et ses défis alimentaires quotidiens. [Sainte-Foy, Qué.]: Presses de l'Université Laval, 2005.
Karen, Bellenir, ed. Diabetes sourcebook: Basic consumer health information about type 1 diabetes (insulin-dependent or juvenile-onset diabetes), Type 2 diabetes (noninsulin-dependent or adult-onset diabetes), gestational diabetes, and related disorders... 2nd ed. Detroit, MI: Omnigraphics, 1999.
Bliss, Michael. La découverte de l'insuline. Saint-Laurent, Québec: Trécarré, 1988.
Bliss, Michael. The discovery of insulin. 2nd ed. Chicago, IL: University of Chicago Press, 2005.
Bliss, Michael. The discovery of insulin. Edinburgh: Harris, 1993.
Bliss, Michael. The discovery of insulin. London: Faber, 1988.
Bliss, Michael. The discovery of insulin. 3rd ed. Toronto: University of Toronto Press, 2000.
Bliss, Michael. Ē anakalypsē tēs insoulinēs =: The discovery of insulin. Greek. Ērakleio: Panepistēmiakes Ekdoseis Krētēs, 1995.
Laisse-moi t'expliquer... Le diabète (de type 1). Midi Trent, 2012.
Base, Beye. Résumé Sur le Diabète, définition du Diabète, Causes du Diabète, les Symptômes du Diabète de Type 1 et Type 2: Tout Ce Que Vous Devez Savoir Sur le Diabète. Independently Published, 2020.
Частини книг з теми "Diabète de type 1 – chirurgie":
Ecochard, Aude Mariani. "Diabète de type 1." In Endocrinologie de l’adolescent, 49–70. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0322-7_6.
Mariani Ecochard, Aude. "Diabète insulinodépendant de type 1 : Prise en charge au diagnostic." In Endocrinologie de l’adolescent, 173–82. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0326-5_27.
"Diabète de type 1." In Méga Guide STAGES IFSI, 523–27. Elsevier, 2015. http://dx.doi.org/10.1016/b978-2-294-74529-4.00164-6.
Alexandre, J., A. Balian, L. Bensoussan, A. Chaïb, G. Gridel, K. Kinugawa, F. Lamazou, et al. "Diabète de type 1." In Le tout en un révisions IFSI, 472–76. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70633-2.50163-3.
Marchand, L., C. Thivolet, A. Decrequy, R. Coutant, and A. Donzeau. "Diabète de type 1." In Diabétologie de L'enfant, 23–40. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-74942-1.00003-3.
Grimaldi, André, and Agnès Hartemann-Heurtier. "Le diabète insulinodépendant ou diabète de type 1." In Guide pratique du diabète, 118–34. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70489-5.00015-1.
Nicolino, M., and C. Villanueva. "Diagnostic différentiel du diabète de type 1." In Diabétologie de L'enfant, 41–61. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-74942-1.00004-5.
Depiesse, Frédéric, and Jean-Luc Grillon. "Diabète de type II et activité physique." In Prescription des Activités Physiques, 121–42. Elsevier, 2016. http://dx.doi.org/10.1016/b978-2-294-74464-8.00006-1.
Halimi, S. "Résultats de la chirurgie bariatrique sur le diabète." In Les Obésités, 591–94. Elsevier, 2021. http://dx.doi.org/10.1016/b978-2-294-76753-1.00104-1.
Briet, C., and I. Allix. "Dépistage des complications du diabète de type 1 chez l’enfant." In Diabétologie de L'enfant, 247–56. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-74942-1.00016-1.
Тези доповідей конференцій з теми "Diabète de type 1 – chirurgie":
Laubner, Katharina, Angeliki Pappa, Anton Gillesen, Marcus Altmeier, Petra Augstein, Sebastian Meyhöfer, Julia K. Mader, et al. "Bariatrische Chirurgie bei Menschen mit Diabetes mellitus Typ 1 oder 2 – eine multizentrische Analyse der DPV-Wiss-Datenbank." In Diabetes. Umwelt. Leben. Perspektiven aus allen Blickwinkeln. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1785344.
Nikiforova, L., N. Sapundzhiev, D. Krumova, B. Spasova, and G. Davidov. "Diagnostic value of the static laryngeal image in laryngomalacia type 1, 2 and 3." In Abstract- und Posterband – 91. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Welche Qualität macht den Unterschied. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1711317.
Elmoutawakkil, N., S. Bouzoubaa, S. Bellemkhannate, and I. Benyahya. "Flux de travail du guidage tridimensionnel en chirurgie orale." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602005.
Ceddaha Zibi, A. "Migraine faciale à expression dentaire, à propos de trois cas." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603016.
Baranes, M., and T. Fortin. "Planification et chirurgie guidée - Avis d’experts : Apports des nouvelles technologies en implantologie : de la planification à la réalisation de la prothèse provisoire immédiate." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206601011.
Nayl, C., M. Fenelon, S. Catros, and J. C. Fricain. "Hémangioendothéliome intravasculaire végétant lingual : à propos d’un cas." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603004.